Celanese Highlights Safe and Effective Drug Delivery Applications of EVA

VitalDose EVA as a controlled release excipient is developed for a wide variety of pharmaceutical products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Celanese Corporation highlighted innovative drug delivery applications of ethylene vinyl acetate (EVA) at CPhI. Celanese shared technical and application-specific information with customers and conference attendees about its broad medical portfolio, specifically highlighting the company’s VitalDose EVA product in emerging pharmaceutical drug delivery applications, including implants for treatment of eye disease, retroviral infection, addiction, and other novel applications. “Controlled-rel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters